About the Company
Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration (FDA) for clinical use.
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic Apparatus
Employees
418
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Axogen, Inc.
Axogen (AXGN) Slid on a Weaker Than Expected Gross Margin
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” second-quarter 2025 investor ...
Axogen, Inc to Participate at Leerink Partners Healthcare ... - Nasdaq
--Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, chairman, chief executive officer, and ...
Raymond James Slashes PT on Axogen (AXGN) to $20 From $21
Axogen, Inc. (NASDAQ:AXGN) is one of the best medical device stocks to buy according to analysts. On August 6, Raymond James ...
Axogen, Inc. Announces Positive Topline Results from REPOSE, a ...
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap Jan. 18, 2024 5:00 PM ET Axogen, Inc. (AXGN) ...
Axogen, Inc. Reports 2023 Third Quarter Financial Results
--Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the third ...
Axogen, Inc. to participate at the Canaccord Genuity 45th ... - Morningstar
ALACHUA, Fla. and TAMPA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of ...
Axogen, Inc. to report 2025 second quarter financial ... - Morningstar
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025 Provided by GlobeNewswire Jul 22, 2025, 1:05:00 PM ...
Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional ...
To get a sense of who is truly in control of Axogen, Inc. (NASDAQ:AXGN), it is important to understand the ownership structure of the business. The group holding the most number of shares in the ...
Axogen, Inc. Appoints Paul G. Thomas to Board of Directors
ALACHUA, Fla., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral ...
Axogen, Inc. Reports 2021 Second Quarter Financial Results
ALACHUA, Fla. and TAMPA, Fla., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve ...
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads ...
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference May 14, 2024 7:00 AM ET Axogen, Inc. (AXGN) ...
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth ...
ALACHUA, Fla. and TAMPA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of ...
Similar Companies
Loading the latest forecasts...